An engineered knottin peptide labeled with 18F for PET imaging of integrin expression

Bioconjugate Chemistry

Volumn 20, Issue 12, 2009, Pages 2342-2347

  Miao, Zheng ^a,b,c   Ren, Gang ^a,b,c   Liu, Hongguang ^a,b,c   Kimura, Richard H ^a,b,d   Jiang, Lei ^a,b,c   Cochran, Jennifer R ^a,b,d   Gambhir, Sanjiv Sam ^a,b,c,d   Cheng, Zhen ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; ECHISTATIN; FLUORINE 18; INTEGRIN; IODINE 125; KNOTTINS; PEPTIDOMIMETIC AGENT; POLYPEPTIDE; SUCCINIMIDYL 4 FLUORINE 18 FLUOROBENZOIC ACID; SUCCINIMIDYL 4 FLUORINE FLUOROBENZOIC ACID; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CANCER CELL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RADIOCHEMISTRY; SOLID PHASE SYNTHESIS;

ECBALLIUM ELATERIUM; MUS;

EID: 72449159210     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900361g     Document Type: Article

References (26)

1. Rothe, A., Hosse, R. J., and Power, B. E. (2006) In vitro display technologies reveal novel biopharmaceutics. FASEB J. 20, 1599-1610. (Pubitemid 44943797)
2. Hosse, R. J., Rothe, A., and Power, B. E. (2006) A new generation of protein display scaffolds for molecular recognition. Protein Sci. 15, 14-27. (Pubitemid 43004229)
3. Uchiyama, F., Tanaka, Y., Minari, Y., and Tokui, N. (2005) Designing scaffolds of peptides for phage display libraries. J. Biosci. Bioeng. 99, 448-456. (Pubitemid 40874522)
4. Nygren, P. A., and Skerra, A. (2004) Binding proteins from alternative scaffolds. J. Immunol. Methods 290, 3-28.
5. Binz, H. K., Amstutz, P., and Pluckthun, A. (2005) Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 23, 1257-1268. (Pubitemid 41486853)
6. Orlova, A., Feldwisch, J., Abrahmsén, L., and Tolmachev, V. (2007) Update: affibody molecules for molecular imaging and therapy for cancer. Cancer Biother. Radiopharm. 22, 573-584. (Pubitemid 350058993)
7. Ladner, R. C. (1999) Polypeptides from phage display: A superior source of in vivo imaging agents. Q. J. Nucl. Med. 43, 119-124.
8. Pallaghy, P. K., Nielsen, K. J., Craik, D. J., and Norton, R. S. (1994) A common structural motif incorporating a cystine knot and a triple-stranded beta-sheet in toxic and inhibitory polypeptides. Protein Sci. 3 1833-1839.
9. Chiche, L., Heitz, A., Gelly, J. C., Gracy, J., Chau, P. T., Ha, P. T., Hernandez, J. F., and Le-Nguyen, D. (2004) Squash inhibitors: from structural motifs to macrocyclic knottins. Curr. Protein Pept. Sci. 5, 341-349. (Pubitemid 39200164)
10. Craik, D. J., Daly, N. L., and Waine, C. (2001) The cystine knot motif in toxins and implications for drug design. Toxicon 39, 43-60.
11. Kimura, R. H., Levin, A. M., Cochran, F. V., and Cochran, J. R. (2009) Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Proteins 77, 359-369.
12. Kimura, R. H., Cheng, Z., Gambhir, S. S., and Cochran, J. R. (2009) Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res. 69, 2435-2442.
13. Zako, T., Nagata, H., Terada, N., Utsumi, A., Sakono, M., Yohda, M., Ueda, H., Soga, K., and Maeda, M. (2009) Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Biochem. Biophys. Res. Commun. 381, 54-58.
14. 18F-labeled alphamelanocyte-stimulating hormone analog. J. Nucl. Med. 48, 987-994.
15. Kumar, C. C., Nie, H., Rogers, C. P., Malkowski, M., Maxwell, E., Catino, J. J., and Armstrong, L. (1997) Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor. J. Pharmacol. Exp. Ther. 283, 843-853. (Pubitemid 27514647)
16. 18F-labeled protein scaffold molecules. J. Nucl. Med. 49, 804-813.
17. Lee, S. B., Hassan, M., Fisher, R., Chertov, O., Chernomordik, V., Kramer-Marek, G., Gandjbakhche, A., and Capala, J. (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin. Cancer Res. 14, 3840-3849.
18. Baum, R., Orlova, A., Tolmachev, V., and Feldwisch, J. (2006) Receptor PET/CT and SPECT using an Affibody molecule for targeting and molecular imaging of HER2-positive cancer in animal xenografts and human breast cancer patients [abstract]. J. Nucl. Med. 47 (suppl), 108P.
19. 99mTc- chelating mercaptoacetyl-glycyl-glycylglycyl (MAG3) sequence. Eur. J. Nucl. Med. Mol. Imaging 34, 722-733.
20. 3 expression in living mice. Bioconjugate Chem. 16, 1433-1441.
21. Chen, X., Park, R., Shahinian, A. H., Tohmea, M., Khankaldyyanb, V., Bozorgzadeha, M. H., Badinga, J. R., Moatsb, R., Laugb, W. E., and Contia, R. S. (2004) 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol. 31, 179-189. (Pubitemid 38315112)
22. 2. J. Nucl. Med. 47, 113-121.
23. Cai, W., Gambhir, S. S., and Chen, X. (2005) Multimodality tumor imaging targeting integrin alpha(v)beta(3). BioTechniques 39, S6-S17.
24. 18F-Labeled PEGylated RGD Peptide. Eur. J. Nucl. Med. Mol. Imaging 31, 1081-1089.
25. Putnam, A. J., Schulz, V. V., Freiter, E. M., Bill, H. M., and Miranti, C. K. (2009) Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion. Cell Commun. Signal 7, 10.
26. Skuli, N., Monferran, S., Delmas, C., Favre, G., Bonnet, J., Toulas, C., and Cohen-Jonathan Moyal, E. (2009) Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res. 69, 3308-3316.